Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elissa K Leonard

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Journal of Biological Chemistry|April 14, 2019
Weaponizing T-cell receptors through molecular engineeringElissa K Leonard, Michael I Leff, Jamie B Spangler
Trends in Pharmacological Sciences|October 28, 2021
Engineered antibody fusion proteins for targeted disease therapyAliyah B Silver, Elissa K Leonard, Joseph R Gould, et al.
Biotechnology and Bioengineering|June 26, 2012
Design and validation of a corneal bioreactorElissa K Leonard, Vincent H Pai, Philip Amberg, et al.
Current Protocols|May 22, 2024
Cytokine/Antibody Fusion Protein Design and EvaluationCharina S Fabilane, A Carson Stephenson, Elissa K Leonard, et al.
Journal of the American Chemical Society|June 8, 2022
Antibody-Invertase Fusion Protein Enables Quantitative Detection of SARS-CoV-2 Antibodies Using Widely Available GlucometersElissa K Leonard, Miguel Aller Pellitero, Boris Juelg, et al.
Matter|December 19, 2022
Supramolecular filaments for concurrent ACE2 docking and enzymatic activity silencing enable coronavirus capture and infection preventionCaleb F Anderson, Qiong Wang, David Stern, et al.
Biorxiv : the Preprint Server for Biology|May 19, 2023
Engineered cytokine/antibody fusion proteins improve delivery of IL-2 to pro-inflammatory cells and promote antitumor activityElissa K Leonard, Jakub Tomala, Joseph R Gould, et al.
Nature Communications|October 14, 2022
Nanoparticle-based modulation of CD4<sup>+</sup> T cell effector and helper functions enhances adoptive immunotherapyAriel Isser, Aliyah B Silver, Hawley C Pruitt, et al.
JCI Insight|August 8, 2024
Engineered cytokine/antibody fusion proteins improve IL-2 delivery to pro-inflammatory cells and promote antitumor activityElissa K Leonard, Jakub Tomala, Joseph R Gould, et al.
Medrxiv : the Preprint Server for Health Sciences|October 21, 2020
IgM autoantibodies recognizing ACE2 are associated with severe COVID-19Livia Casciola-Rosen, David R Thiemann, Felipe Andrade, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Journal of Biological Chemistry|April 14, 2019
Weaponizing T-cell receptors through molecular engineeringElissa K Leonard, Michael I Leff, Jamie B Spangler
Trends in Pharmacological Sciences|October 28, 2021
Engineered antibody fusion proteins for targeted disease therapyAliyah B Silver, Elissa K Leonard, Joseph R Gould, et al.
Biotechnology and Bioengineering|June 26, 2012
Design and validation of a corneal bioreactorElissa K Leonard, Vincent H Pai, Philip Amberg, et al.
Current Protocols|May 22, 2024
Cytokine/Antibody Fusion Protein Design and EvaluationCharina S Fabilane, A Carson Stephenson, Elissa K Leonard, et al.
Journal of the American Chemical Society|June 8, 2022
Antibody-Invertase Fusion Protein Enables Quantitative Detection of SARS-CoV-2 Antibodies Using Widely Available GlucometersElissa K Leonard, Miguel Aller Pellitero, Boris Juelg, et al.
Matter|December 19, 2022
Supramolecular filaments for concurrent ACE2 docking and enzymatic activity silencing enable coronavirus capture and infection preventionCaleb F Anderson, Qiong Wang, David Stern, et al.
Biorxiv : the Preprint Server for Biology|May 19, 2023
Engineered cytokine/antibody fusion proteins improve delivery of IL-2 to pro-inflammatory cells and promote antitumor activityElissa K Leonard, Jakub Tomala, Joseph R Gould, et al.
Nature Communications|October 14, 2022
Nanoparticle-based modulation of CD4<sup>+</sup> T cell effector and helper functions enhances adoptive immunotherapyAriel Isser, Aliyah B Silver, Hawley C Pruitt, et al.
JCI Insight|August 8, 2024
Engineered cytokine/antibody fusion proteins improve IL-2 delivery to pro-inflammatory cells and promote antitumor activityElissa K Leonard, Jakub Tomala, Joseph R Gould, et al.
Medrxiv : the Preprint Server for Health Sciences|October 21, 2020
IgM autoantibodies recognizing ACE2 are associated with severe COVID-19Livia Casciola-Rosen, David R Thiemann, Felipe Andrade, et al.
Pageof 2